Insignia
Device Joint Replacement Hips, Knees
PDI 07613327511390
General payments
$6,597,798
Research payments
$958,368
Through program year 2025, $6,597,798 in general payments and $958,368 in research payments were reported against Insignia (Joint Replacement Hips, Knees).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $3,626,933 | 3,952 |
| 2025 | Research | $59,475 | 10 |
| 2024 | General | $1,664,798 | 3,254 |
| 2024 | Research | $473,210 | 82 |
| 2023 | General | $1,051,959 | 2,340 |
| 2023 | Research | $269,804 | 57 |
| 2022 | General | $250,607 | 983 |
| 2022 | Research | $155,879 | 13 |
| 2021 | General | $3,500 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 46 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 48 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
10,530 general · 162 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.